General information about company
Scrip code	526546
NSE Symbol
MSEI Symbol
ISIN*	INE493D01013
Name of company	CHOKSI LABORATORIES LIMITED
Type of company
Class of security	Equity
Date of start of financial year	01-04-2021
Date of end of financial year	31-03-2022
Date of board meeting when results were approved	28-05-2022
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	16-05-2022
Description of presentation currency	INR
Level of rounding used in financial results	Lakhs
Reporting Quarter	Yearly
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited	Audited
Segment Reporting	Single segment
Description of single segment	Single segment
Start date and time of board meeting	28-05-2022 14:30
End date and time of board meeting	28-05-2022 16:30
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2022	01-04-2021
B	Date of end of reporting period	31-03-2022	31-03-2022
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	1013.79	3004.21
	Other income	2.17	11.96
	Total income	1015.96	3016.17
2	Expenses
(a)	Cost of materials consumed	45.15	198.34
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	0	0
(d)	Employee benefit expense	314.65	1200.93
(e)	Finance costs	75.98	320.89
(f)	Depreciation, depletion and amortisation expense	134.63	542.78
(f)	Other Expenses
1	Laboratory Maintainance Expenses	69.43	249.29
2	Power & Fuel	15.74	69.81
3	Other Expenses	99.21	397.43
10
	Total other expenses	184.38	716.53
	Total expenses	754.79	2979.47

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2022	01-04-2021
B	Date of end of reporting period	31-03-2022	31-03-2022
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
3	Total profit before exceptional items and tax	261.17	36.7
4	Exceptional items	0	0
5	Total profit before tax	261.17	36.7
7	Tax expense
8	Current tax	0	0
9	Deferred tax	37.27	16
10	Total tax expenses	37.27	16
11	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
14	Net Profit Loss for the period from continuing operations	223.9	20.7
15	Profit (loss) from discontinued operations before tax	0	0
16	Tax expense of discontinued operations	0	0
17	Net profit (loss) from discontinued operation after tax	0	0
19	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
21	Total profit (loss) for period	223.9	20.7
22	Other comprehensive income net of taxes	-15.05	-5.06

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2022	01-04-2021
B	Date of end of reporting period	31-03-2022	31-03-2022
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
23	Total Comprehensive Income for the period	208.85	15.64
24	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
25	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	0	0
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
26	Details of equity share capital
	Paid-up equity share capital	696.52	696.52
	Face value of equity share capital	10	10
27	Details of debt securities
28	Reserves excluding revaluation reserve		0
29	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	3.21	0.3
	Diluted earnings (loss) per share from continuing operations	3.21	0.3
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	3.21	0.3
	Diluted earnings (loss) per share from continuing and discontinued operations	3.21	0.3
30	Debt equity ratio
31	Debt service coverage ratio
32	Interest service coverage ratio
33	Disclosure of notes on financial results

Statement of Asset and Liabilities
Particulars		Current year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2021
Date of end of reporting period		31-03-2022
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	4418.63
	Capital work-in-progress	155.59
	Investment property	0
	Goodwill	0
	Other intangible assets	21.03
	Intangible assets under development	11
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	0
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	69.6
	Total non-current financial assets	69.6
	Deferred tax assets (net)	139.07
	Other non-current assets	225.7
	Total non-current assets	5040.62
2	Current assets
	Inventories	25.04
	Current financial asset
	Current investments	0
	Trade receivables, current	1029.14
	Cash and cash equivalents	40.71
	Bank balance other than cash and cash equivalents	0
	Loans, current	0
	Other current financial assets	6.62
	Total current financial assets	1076.47
	Current tax assets (net)	0
	Other current assets	304.48
	Total current assets	1405.99

Statement of Asset and Liabilities
Particulars		Current year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2021
Date of end of reporting period		31-03-2022
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	6446.61
	Equity and liabilities
	Equity
	Equity attributable to owners of parent
	Equity share capital	696.53
	Other equity	1093.73
	Total equity attributable to owners of parent	1790.26
	Non controlling interest
	Total equity	1790.26
	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	2753.74
	Trade payables, non-current	0
	Other non-current financial liabilities	206.41
	Total non-current financial liabilities	2960.15
	Provisions, non-current	138.91
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	3099.06
	Current liabilities
	Current financial liabilities
	Borrowings, current	722.2
	Trade payables, current	401.57
	Other current financial liabilities	46.54
	Total current financial liabilities	1170.31
	Other current liabilities	355.88
	Provisions, current	31.1
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	1557.29
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	4656.35
	Total equity and liabilites	6446.61
	Disclosure of notes on assets and liabilities	Textual Information(1)

Text Block

Textual Information(1)

Notes to the results : 1 The above Financial Results for the quarter and year ended 31st March 2022 have been reviewed by the Audit Committee and approved & taken on record by the Board at their Board meeting held on 28th May 2022, Saturday. 2 Depreciation on fixed assets is provided on straight line method as per the estimated remaining useful life of assets. 3 The Company has identified "Analysis and Testing" as the single operating segment for the continued operations in the financial statements as per Ind AS 108 "Operating Segments. 4 Figures for the previous periods have been regrouped/rearranged, wherever necessary and minus figures are shown in brackets. 5 The Company has adopted Ind As 116 "Leases" and applied the same at all existing contacts as on March 31, 2022. Accordingly the Company has recognized a leases liability measured at the present value of the remaining leases payments, and right-of-use (ROU) asset at an amount equal to leases liability (adjusted for any related repayments). however the impact on the loss and earnings per share is accordingly affected. 6 The figures for the quarter ended March 31, 2022 and March 31, 2021 are the balancing figures between the audited figures in respect of full financial year and the unaudited published year to date figures up to the third quarter of the relevant financial year which were subject to limited review by the statutory Auditor of the Company. 7 The above financial results have been prepared as per the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015and in accordance with the Companies (lndian Accounting Standards) Rules, 2015 (lnd AS) as amended, prescribed under Section 133 of the Companies Act, 2013, read withrelevant rules issued thereunder and other accounting principles generally accepted in India. 8 Earnings per share amount is shown in Rupees. 9 The company continued to consider the impact of COVID-19 pandemic in assessing the recoverability of receivable, intangible assets and certain advances. For this purpose, the company considered internal and external source of information up to the date of approval of these financial results. The company, based on its judgments, estimates and assumptions including sensitive analysis, expect to fully recover the carrying amount of receivables intangible assets and other advances/ assets the company will continue to closely monitor any material change of future economic condition. 10 For any queries e_mail at compliance_officer@choksilab.com

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-01-2022	01-04-2021
Date of end of reporting period		31-03-2022	31-03-2022
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets
	Net Segment Asset
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities
	Net Segment Liabilities
	Disclosure of notes on segments

Cash flow statement, indirect
Particulars		Year ended (dd-mm-yyyy)
A	Date of start of reporting period	01-04-2021
B	Date of end of reporting period	31-03-2022
C	Whether results are audited or unaudited	Audited
D	Nature of report standalone or consolidated	Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax	36.7
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs	320.89
	Adjustments for decrease (increase) in inventories	-13.84
	Adjustments for decrease (increase) in trade receivables, current	-213.08
	Adjustments for decrease (increase) in trade receivables, non-current	0
	Adjustments for decrease (increase) in other current assets	21.89
	Adjustments for decrease (increase) in other non-current assets	23.34
	Adjustments for other financial assets, non-current	0
	Adjustments for other financial assets, current	-3.84
	Adjustments for other bank balances	0
	Adjustments for increase (decrease) in trade payables, current	-81.46
	Adjustments for increase (decrease) in trade payables, non-current	0
	Adjustments for increase (decrease) in other current liabilities	25.76
	Adjustments for increase (decrease) in other non-current liabilities	0
	Adjustments for depreciation and amortisation expense	542.78
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss	0
	Adjustments for provisions, current	-2.67
	Adjustments for provisions, non-current	0
	Adjustments for other financial liabilities, current	0
	Adjustments for other financial liabilities, non-current	0
	Adjustments for unrealised foreign exchange losses gains	0
	Adjustments for dividend income	0
	Adjustments for interest income	0
	Adjustments for share-based payments	0
	Adjustments for fair value losses (gains)	-0.35
	Adjustments for undistributed profits of associates	0
	Other adjustments for which cash effects are investing or financing cash flow	0
	Other adjustments to reconcile profit (loss)	0
	Other adjustments for non-cash items	0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships	0
	Total adjustments for reconcile profit (loss)	619.42
	Net cash flows from (used in) operations	656.12
	Dividends received	0
	Interest paid	0
	Interest received	-11.61
	Income taxes paid (refund)	-117.86
	Other inflows (outflows) of cash	25.38
	Net cash flows from (used in) operating activities	787.75
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses	0
	Cash flows used in obtaining control of subsidiaries or other businesses	0
	Other cash receipts from sales of equity or debt instruments of other entities	0
	Other cash payments to acquire equity or debt instruments of other entities	0
	Other cash receipts from sales of interests in joint ventures	0
	Other cash payments to acquire interests in joint ventures	0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships	0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships	0
	Proceeds from sales of property, plant and equipment	3.76
	Purchase of property, plant and equipment	98.28
	Proceeds from sales of investment property	0
	Purchase of investment property	0
	Proceeds from sales of intangible assets	0
	Purchase of intangible assets	18.31
	Proceeds from sales of intangible assets under development	0
	Purchase of intangible assets under development	0
	Proceeds from sales of goodwill	0
	Purchase of goodwill	0
	Proceeds from biological assets other than bearer plants	0
	Purchase of biological assets other than bearer plants	0
	Proceeds from government grants	0
	Proceeds from sales of other long-term assets	0
	Purchase of other long-term assets	0
	Cash advances and loans made to other parties	0
	Cash receipts from repayment of advances and loans made to other parties	0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts	0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts	0
	Dividends received	0
	Interest received	11.61
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	-169.67
	Net cash flows from (used in) investing activities	-270.89
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries	0
	Payments from changes in ownership interests in subsidiaries	0
	Proceeds from issuing shares	0
	Proceeds from issuing other equity instruments	0
	Payments to acquire or redeem entity's shares	0
	Payments of other equity instruments	0
	Proceeds from exercise of stock options	0
	Proceeds from issuing debentures notes bonds etc	0
	Proceeds from borrowings	0
	Repayments of borrowings	144.92
	Payments of finance lease liabilities	0
	Payments of lease liabilities	40.95
	Dividends paid	0
	Interest paid	320.89
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) financing activities	-506.76
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes	10.1
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents	0
	Net increase (decrease) in cash and cash equivalents	10.1
	Cash and cash equivalents cash flow statement at beginning of period	30.61
	Cash and cash equivalents cash flow statement at end of period	40.71